Cartesian Therapeutics 2024财年GAAP每股收益$(4.49)优于预期$(4.98),销售额$38.913百万低于预期$39.777百万

财报速递
13 Mar
Cartesian Therapeutics 2024财年GAAP每股收益$(4.49)优于预期$(4.98),销售额$38.913百万低于预期$39.777百万

以上内容来自Benzinga Earnings专栏,原文如下:

Cartesian Therapeutics FY 2024 GAAP EPS $(4.49) Beats $(4.98) Estimate, Sales $38.913M Miss $39.777M Estimate

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10